NASDAQ:DOVA - Dova Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Dova Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $28.04 0.00 (0.00 %) (As of 11/12/2019) Add Compare Today's Range$28.04Now: $28.04▼$28.0450-Day Range$28.04MA: $28.04▼$28.0452-Week Range$5.62Now: $28.04▼$28.54Volume35,036 shsAverage Volume499,313 shsMarket Capitalization$807.55 millionP/E RatioN/ADividend YieldN/ABeta2.74 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Dova Pharmaceuticals, Inc, a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia disease. The company's lead product candidate is DOPTELET that is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure. It also develops DOPTELET for the treatment of chronic immune thrombocytopenia and chemotherapy-induced thrombocytopenia. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DOVA Previous Symbol CUSIPN/A CIK1685071 Webhttp://www.dova.com/ Phone919-748-5975Debt Debt-to-Equity Ratio0.41 Current Ratio5.64 Quick Ratio5.37Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$10.35 million Price / Sales78.02 Cash FlowN/A Price / Cash FlowN/A Book Value$2.71 per share Price / Book10.35Profitability EPS (Most Recent Fiscal Year)($2.60) Net Income$-72,280,000.00 Net Margins-544.09% Return on Equity-101.60% Return on Assets-67.21%Miscellaneous Employees115 Outstanding Shares28,800,000Market Cap$807.55 million Next Earnings DateN/A OptionableOptionable Receive DOVA News and Ratings via Email Sign-up to receive the latest news and ratings for DOVA and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:DOVA Rates by TradingView Dova Pharmaceuticals (NASDAQ:DOVA) Frequently Asked Questions What is Dova Pharmaceuticals' stock symbol? Dova Pharmaceuticals trades on the NASDAQ under the ticker symbol "DOVA." How were Dova Pharmaceuticals' earnings last quarter? Dova Pharmaceuticals Inc (NASDAQ:DOVA) released its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.60) EPS for the quarter, missing analysts' consensus estimates of ($0.57) by $0.03. The firm earned $3.52 million during the quarter, compared to analyst estimates of $5.63 million. Dova Pharmaceuticals had a negative return on equity of 101.60% and a negative net margin of 544.09%. View Dova Pharmaceuticals' Earnings History. What price target have analysts set for DOVA? 6 brokers have issued 1-year target prices for Dova Pharmaceuticals' stock. Their forecasts range from $15.00 to $30.00. On average, they expect Dova Pharmaceuticals' share price to reach $26.42 in the next year. This suggests that the stock has a possible downside of 5.8%. View Analyst Price Targets for Dova Pharmaceuticals. What is the consensus analysts' recommendation for Dova Pharmaceuticals? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dova Pharmaceuticals in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Dova Pharmaceuticals. Has Dova Pharmaceuticals been receiving favorable news coverage? Headlines about DOVA stock have been trending positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dova Pharmaceuticals earned a daily sentiment score of 2.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Dova Pharmaceuticals. Who are some of Dova Pharmaceuticals' key competitors? Some companies that are related to Dova Pharmaceuticals include Apellis Pharmaceuticals (APLS), Agios Pharmaceuticals (AGIO), Axsome Therapeutics (AXSM), Zai Lab (ZLAB), Biohaven Pharmaceutical (BHVN), Emergent Biosolutions (EBS), Genmab A/S (GMAB), Alkermes (ALKS), Uniqure (QURE), Karuna Therapeutics (KRTX), Amicus Therapeutics (FOLD), ChemoCentryx (CCXI), ArQule (ARQL), Zogenix (ZGNX) and Epizyme (EPZM). What other stocks do shareholders of Dova Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dova Pharmaceuticals investors own include Global Blood Therapeutics (GBT), Arrowhead Pharmaceuticals (ARWR), Sasol (SSL), Aldeyra Therapeutics (ALDX), TESARO (TSRO), TherapeuticsMD (TXMD), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE), Heron Therapeutics (HRTX) and Immunomedics (IMMU). Who are Dova Pharmaceuticals' key executives? Dova Pharmaceuticals' management team includes the folowing people: Dr. David S. Zaccardelli, Pres & CEO (Age 54)Mr. Mark W. Hahn, CFO & Sec. (Age 56)Mr. Kevin Laliberte, Sr. VP of Product Devel. (Age 41)Mr. Jason Levine, VP of MarketingMr. Ilija Zlatar, Head of U.S. Sales When did Dova Pharmaceuticals IPO? (DOVA) raised $66 million in an initial public offering on Thursday, June 29th 2017. The company issued 4,100,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Jefferies and Leerink Partners acted as the underwriters for the IPO. How do I buy shares of Dova Pharmaceuticals? Shares of DOVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Dova Pharmaceuticals' stock price today? One share of DOVA stock can currently be purchased for approximately $28.04. How big of a company is Dova Pharmaceuticals? Dova Pharmaceuticals has a market capitalization of $807.55 million and generates $10.35 million in revenue each year. The company earns $-72,280,000.00 in net income (profit) each year or ($2.60) on an earnings per share basis. Dova Pharmaceuticals employs 115 workers across the globe.View Additional Information About Dova Pharmaceuticals. What is Dova Pharmaceuticals' official website? The official website for Dova Pharmaceuticals is http://www.dova.com/. How can I contact Dova Pharmaceuticals? Dova Pharmaceuticals' mailing address is 240 Leigh Farm Road Suite 245, Durham NC, 27707. The company can be reached via phone at 919-748-5975 or via email at [email protected] MarketBeat Community Rating for Dova Pharmaceuticals (NASDAQ DOVA)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 214 (Vote Outperform)Underperform Votes: 216 (Vote Underperform)Total Votes: 430MarketBeat's community ratings are surveys of what our community members think about Dova Pharmaceuticals and other stocks. Vote "Outperform" if you believe DOVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DOVA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2020 by MarketBeat.com StaffFeatured Article: How can investors invest in the S&P/TSX Index?
